Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
MULTIPHARMA GROUP from Anderlecht, company number BE0401995516, closed financial year 2025 with a result of € -242,114 after tax. Compared with financial year 2024, the result moved from € -60,057 to € -242,114. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 164.7 million
▲ 25% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -242,114
▼ 303 % more loss than in 2024
Profit after tax over the fiscal year.
€ 250,731
▲ 186% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 120.2 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 28,585
▲ € 24,835 vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 31 days on average.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € -115,388 | € 43,818,756 | € -60,057 | € -242,114 | ▼ € 182,057 |
| Equity | € 88,497,864 | € 131,809,920 | € 131,244,162 | € 164,699,047 | ▲ 25% |
| Total debts | € 527,352 | € 527,033 | € 522,997 | € 1,344,138 | ▲ 157% |
| Cash | € 967,389 | € 229,037 | € 87,566 | € 250,731 | ▲ 186% |
| Retained profit | € 79,032,939 | € 122,344,995 | € 121,778,238 | € 120,233,123 | ▼ 1% |
| Dividend | € 506,700 | € 506,700 | € 506,700 | € 1,303,000 | ▲ 157% |
| Balance sheet total | € 89,025,216 | € 132,336,953 | € 131,767,159 | € 166,043,185 | ▲ 26% |
Key figures of MULTIPHARMA GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MULTIPHARMA GROUP?
What happened at MULTIPHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Gaetane D'HOERAENE stepped down as director. NBB
- Michel LUTTGENS stepped down as director. NBB
- Jimmy SCHEVERNELS stepped down as director. NBB
- Jean-Pierre DI BARTOLOMEO stepped down as director. NBB
- Johan DEKENS stepped down as director. NBB
- Martine MAGNEE stepped down as director. NBB
- Alain THIRION stepped down as director. NBB
- Julie RICHER stepped down as director. NBB
In short
From € 115,388 loss in 2022 to € 242,114 loss in 2025.
Paid € 7,147 in corporate taxes since 2022.
Best year ever: 2023, with € 43.8 million profit.
Paid out € 2.8 million in dividends to the owners in total.
Management
The shares are held by La maison de la Solidarité V.Z.W. (10%), Financière Botanique S.A. (10%), Vilvo Invest (9.9%), Solidaris Assurance (9.9%), P&V Previdis C.V. (9.9%) and Barsis C.V. (9.9%). It owns 100% of Multipharma C.V. itself.
Directors
According to the 2025 annual accounts
Jean-Paul PHILIPPOT
Director
since 2025 · until 2026
since 2025 · until 2026
Gaetane D'HOERAENE
Director
Also active at: MAISON DE LA SOLIDARITE, Les Rièzes et les Sarts, Latitude Jeunes du Centre, Charleroi et Soignies, POINT SANTE
since 2025 · until 2028
Geert REYNIERS
Managing director
Also active at: APOTHEEK SMISHOEK, Apotheek Willebroek, Apoteek Jespers - Cuijpers, APOTHEEK BOGAERT, APOTEEK P. Sergeant, APOTHEEK VANDYCK, PHARMACIE LAURENT DELCOURT, Farmannso +12 more
since 2024 · until 2027
since 2025 · until 2028
Jimmy SCHEVERNELS
Director
since 2025 · until 2028
since 2024 · until 2027
Jean-Pierre DI BARTOLOMEO
Director
Also active at: FONDS DE PARTICIPATION WALLONIE, Centrale des métiers de Liège, NOVALLIA, Transeo, WALLONIE ENTREPRENDRE INTERNATIONAL, SOCIETE WALLONNE POUR LE FINANCEMENT DES INFRASTUCTURES DES POLES DE COMPETITIVITES, WE Accompagnement et Stratégie
since 2025 · until 2028
Mieke VANMARCKE
Director
Also active at: MAISON DE LA SOLIDARITE, Vlaams Socialistisch Gezondheidsfonds, Belle-Vue, I.M.
since 2023 · until 2026
since 2022 · until 2025
since 2025 · until 2028
since 2024 · until 2027
since 2025 · until 2028
Alain THIRION
Director
Also active at: MAISON DE LA SOLIDARITE, Esenca asbl, LIAGES ASBL, Soralia, Les Rièzes et les Sarts, AUTONOMIS-RESEAU SOLIDARIS, SOLIDARIS ENERGIE TRAVAUX MARCHES PUBLICS, ACTION FRANCOPHONE POUR LA FORMATION
since 2025 · until 2028
Julie RICHER
Director
since 2025 · until 2028
Shareholders
9.9%
9.9%
9.9%
9.9%
9.5%
0.9%
0.4%
0.2%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Marie Curiesquare 30
1070 Anderlecht
Lennikse Baan 900
1070 Anderlecht
Active since 7 September 1901
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →APOTEEK HANCOUR
€ 133,498 gross margin · 2025
Office des sociétés coopératives de grossistes pharmaceutiques et de pharmacies - Vereniging van coöperatieve vennootschappen van farmaceutische groothandelaars en apotheken
Apoteek Jespers - Cuijpers same network
€ 113,239 gross margin · 2025
APOTEEK P. Sergeant same network
€ 10,336 gross margin · 2025
APOTHEEK VANDYCK same network
€ 1,703 gross margin · 2025
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0401.995.516
- VAT number
- BE 0401.995.516
- Registered office
- Marie Curiesquare 30, 1070 Anderlecht
- Names & denominations
- MULTIPHARMA GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 17 July 1912
- Peppol
- Not registered